Trial Profile
Efficacy of bazedoxifene on vascular endothelial function in postmenopausal women with osteoporosis
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary) ; Risedronic acid
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Pharmacodynamics
- 21 Feb 2013 New trial record